RHS
Click for more information
0.00% 27.5¢ rhs limited

Ann: RHS Investor Presentation November 2016, page-4

  1. bevter
    25,625 Posts.
    lightbulb Created with Sketch. 1213
    clock Created with Sketch.
    16/12/16
    20:16
    Post #: 21402212
    Highlights • Revenue update • Flinders Fertility commence IVF and PGS cycles at new co-location facility • DOPlifyTM included in independent single cell WGA benchmarking study • RHS to present at 9th Annual Biotech Showcase – San Francisco Jan. 11th 2017 • Tristan Hardy appointed to the RHS Clinical and Scientific Advisory Committee
    RHS Price at posting: 7.1¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
right-arrow Created with Sketch.
GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
NEWS What matters for FY25: Investment; interest rates; inflation & elections
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RHS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.